Trials / Conditions / Delusional Disorder

Delusional Disorder

26 registered clinical trials studyying Delusional Disorder — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Shared Decision Making for Antipsychotic Medications NCT05416658	New York State Psychiatric Institute	N/A
Not Yet Recruiting	Enhancing Veteran-Clinical Collaboration in VA PRRCs NCT06898879	VA Office of Research and Development	N/A
Active Not Recruiting	Young Adults With Violent Behavior During Early Psychosis (Aim 2) NCT05756855	Columbia University	N/A
Recruiting	The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care NCT06005766	University of Jyvaskyla	N/A
Unknown	SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities NCT06007105	London School of Hygiene and Tropical Medicine	N/A
Recruiting	Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services NCT06740383	Beth Israel Deaconess Medical Center	—
Recruiting	Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders NCT06423651	Universitat Autonoma de Barcelona	N/A
Completed	Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness NCT04324944	VA Office of Research and Development	N/A
Enrolling By Invitation	Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement NCT04323566	Uppsala University Hospital	Phase 2
Completed	Feasibility of a Novel Process-based Treatment for Patients With Psychosis NCT04874974	Max-Planck-Institute of Psychiatry	N/A
Active Not Recruiting	The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosi NCT04916626	Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital	N/A
Completed	Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders NCT04783285	CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas	N/A
Completed	Research Into Antipsychotic Discontinuation and Reduction Trial NCT03559426	University College, London	Phase 4
Completed	D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions NCT01981759	NYU Langone Health	Phase 4
Completed	Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia NCT02787122	Philipps University Marburg	N/A
Completed	Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) NCT01822418	Central Institute of Mental Health, Mannheim	Phase 4
Completed	Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis NCT01216891	Research Foundation for Mental Hygiene, Inc.	N/A
Completed	Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. NCT00716755	Centre for Addiction and Mental Health	N/A
Completed	Acceptance and Commitment Therapy for Delusions NCT00657631	Weill Medical College of Cornell University	N/A
Terminated	Schizophrenic Patients Taking Part in Integrated Care Program NCT00617214	AstraZeneca	—
Terminated	Anticholinergic Burden in Schizophrenia NCT00715377	Centre for Addiction and Mental Health	N/A
Unknown	Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Ps NCT00465920	University of Cologne	Phase 2
Unknown	Integrated Care in Psychotic Disorders With Severe Mental Illness NCT01888627	Universitätsklinikum Hamburg-Eppendorf	N/A
Unknown	Trial of Cognitive Behavioral Therapy for Schizophrenia NCT00300651	Philipps University Marburg	Phase 3
Completed	Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus NCT00222807	University of Pittsburgh	—
Completed	A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment NCT00644800	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4